Evidence map›Paper›PMID 31572339›Full record

ArticleFrontiers in microbiology2019

Fueling Open Innovation for Malaria Transmission-Blocking Drugs: Hundreds of Molecules Targeting Early Parasite Mosquito Stages.

Michael Delves, M Jose Lafuente-Monasterio, Leanna Upton, Andrea Ruecker, Didier Leroy, Francisco-Javier Gamo, Robert Sinden

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Streamlined and Robust Stage-Specific Profiling of Gametocytocidal Compounds AgainstFrontiers in cellular and infection microbiology · 2022
    Article
  11. Adapt or Die: Targeting Unique Transmission-Stage Biology for Malaria Elimination.Frontiers in cellular and infection microbiology · 2022
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. A Hetero-Multimeric Chitinase-ContainingFrontiers in cellular and infection microbiology · 2020
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael DelvesDepartment of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
M Jose Lafuente-MonasterioDiseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Spain.
Leanna UptonDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Andrea RueckerDepartment of Life Sciences, Imperial College London, London, United Kingdom.
Didier LeroyMedicines for Malaria Venture, Geneva, Switzerland.
Francisco-Javier GamoDiseases of the Developing World (DDW), GlaxoSmithKline, Tres Cantos, Spain.
Robert SindenDepartment of Life Sciences, Imperial College London, London, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

backgroundDespite recent successes at controlling malaria, progress has stalled with an estimated 219 million cases and 435,000 deaths in 2017 alone. Combined with emerging resistance to front line antimalarial therapies in Southeast Asia, there is an urgent need for new treatment options and novel approaches to halt the spread of malaria.

methods13,533 small molecules with known activity against

results437 molecules inhibited

conclusionThe

Indexed as

drugmalariaookinetescreeningtransmission

Identifiers

PMID31572339
PMCPMC6753678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.